7 Recruiting Multiple Myeloma Clinical Trials in Illinois
Explore active multiple myeloma research studies enrolling across Illinois. Verify eligibility and contact site coordinators.
📍 Find Near Me by DistanceBrowse by City
Recruiting Multiple Myeloma Studies in Illinois
🔵 Active, Not Recruiting Observational / Diagnostic ⚙️ Medical Device Protocol
Study to Assess for Measurable Residual Disease (MRD) in Multiple Myeloma Patients
📍 University Of Chicago Medicine Comprehensive Cancer Center — Chicago, Illinois
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic
Carfilzomib, Lenalidomide, and Dexamethasone Versus Bortezomib, Lenalidomide and Dexamethasone (KRd vs. VRd) in Patients With Newly Diagnosed Multiple Myeloma (COBRA)
📍 University Of Chicago Medicine Comprehensive Cancer Center — Chicago, Illinois
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic
Trial of Carfilzomib, Lenalidomide, Dexamethasone Versus Lenalidomide Alone After Stem-cell Transplant for Multiple Myeloma
📍 University of Chicago — Chicago, Illinois
View Study & Checklist ➔ 🟢 Recruiting Phase2 💊 Investigational Drug / Biologic
Post-Autologous Transplant Maintenance With Isatuximab and Lenalidomide in Minimal Residual Disease Positive Multiple Myeloma
📍 University of Illinois at Chicago — Chicago, Illinois
View Study & Checklist ➔ 🟢 Recruiting Phase2 💊 Investigational Drug / Biologic
Study of Belantamab Mafodotin With Carfilzomib, Pomalidomide, and Dexamethasone in Relapsed Multiple Myeloma
📍 University of Chicago Medicine Comprehensive Cancer Center — Chicago, Illinois
View Study & Checklist ➔ 🟢 Recruiting Phase1 📋 Clinical Research Protocol
Hypofractionation (Radiation) Trial for Multiple Myeloma
📍 The University of Chicago Comprehensive Cancer Center — Chicago, Illinois
View Study & Checklist ➔ 🟢 Recruiting Phase1 📋 Clinical Research Protocol
Free From Maintenance Drug Therapy in Multiple Myeloma (The FREEDMM Trial) for Minimal Residual Disease (MRD
📍 University of Illinois Cancer Center — Chicago, Illinois
View Study & Checklist ➔